Joshua P Thaler

Dr. Joshua P Thaler


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Cell Metabolism
Verified
Journal Article
Closed access
MVMartin Valdearcos
Martin Valdearcos
JDJohn D. Douglass
John D. Douglass
MRMegan M. Robblee
Megan M. Robblee
MDMauricio D. Dorfman
Mauricio D. Dorfman
DSDaniel R. Stifler
Daniel R. Stifler
SKSuneil K. Koliwad
Suneil K. Koliwad

27 April 2010 in Diabetes
Verified
Journal Article
Open access
DSDavid A. Sarruf
David A. Sarruf
JTJoshua P Thaler
Joshua P Thaler
GMGregory J. Morton
Gregory J. Morton
JGJonathan German
Jonathan German
JFJonathan D. Fischer
Jonathan D. Fischer
MSMichael W. Schwartz
Michael W. Schwartz
OBJECTIVE: The hormone fibroblast growth factor 21 (FGF21) exerts diverse, beneficial effects on energy balance and insulin sensitivity when administered systemically to rodents with diet-induced obesity (DIO). The current studies investigate whether central FGF21 treatment recapitulates these effects. RESEARCH DESIGN AND METHODS: After preliminary dose-finding studies, either saline vehicle or recombinant human FGF21 (0.4 μg/day) was infused continuously for 2 weeks into the lateral cerebral ventricle of male Wistar rats rendered obese by high-fat feeding. Study end points included measures of energy balance (body weight, body composition, food intake, energy expenditure, and circulating and hepatic lipids) and glucose metabolism (insulin tolerance test, euglycemic-hyperinsulinemic clamp, and hepatic expression of genes involved in glucose metabolism). RESULTS: Compared with vehicle, continuous intracerebroventricular infusion of FGF21 increased both food intake and energy expenditure in rats with DIO, such that neither body weight nor body composition was altered. Despite unchanged body fat content, rats treated with intracerebroventricular FGF21 displayed a robust increase of insulin sensitivity due to increased insulin-induced suppression of both hepatic glucose production and gluconeogenic gene expression, with no change of glucose utilization. CONCLUSIONS: FGF21 action in the brain increases hepatic insulin sensitivity and metabolic rate in rats with DIO. These findings identify the central nervous system as a potentially important target for the beneficial effects of FGF21 in the treatment of diabetes and obesity.

1 April 2017 in Molecular Metabolism
Verified
Journal Article
Open access
JDJ.D. Douglass
J.D. Douglass
MDM D Dorfman
M D Dorfman
RFR. Fasnacht
R. Fasnacht
LSL.D. Shaffer
L.D. Shaffer
JTJoshua P Thaler
Joshua P Thaler
Obesity and high fat diet (HFD) consumption in rodents is associated with hypothalamic inflammation and reactive gliosis. While neuronal inflammation promotes HFD-induced metabolic dysfunction, the role of astrocyte activation in susceptibility to hypothalamic inflammation and diet-induced obesity (DIO) remains uncertain. Metabolic phenotyping, immunohistochemical analyses, and biochemical analyses were performed on HFD-fed mice with a tamoxifen-inducible astrocyte-specific knockout of IKKβ (GfapCreERIkbkbfl/fl, IKKβ-AKO), an essential cofactor of NF-κB-mediated inflammation. IKKβ-AKO mice with tamoxifen-induced IKKβ deletion prior to HFD exposure showed equivalent HFD-induced weight gain and glucose intolerance as Ikbkbfl/fl littermate controls. In GfapCreERTdTomato marker mice treated using the same protocol, minimal Cre-mediated recombination was observed in the mediobasal hypothalamus (MBH). By contrast, mice pretreated with 6 weeks of HFD exposure prior to tamoxifen administration showed substantially increased recombination throughout the MBH. Remarkably, this treatment approach protected IKKβ-AKO mice from further weight gain through an immediate reduction of food intake and increase of energy expenditure. Astrocyte IKKβ deletion after HFD exposure-but not before-also reduced glucose intolerance and insulin resistance, likely as a consequence of lower adiposity. Finally, both hypothalamic inflammation and astrocytosis were reduced in HFD-fed IKKβ-AKO mice. These data support a requirement for astrocytic inflammatory signaling in HFD-induced hyperphagia and DIO susceptibility that may provide a novel target for obesity therapeutics.

22 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MDMauricio D. Dorfman
Mauricio D. Dorfman
JKJordan E. Krull
Jordan E. Krull
JDJohn D. Douglass
John D. Douglass
RFRachael Fasnacht
Rachael Fasnacht
FLFernando Lara-Lince
Fernando Lara-Lince
JTJoshua P Thaler
Joshua P Thaler
Female mice are less susceptible to the negative metabolic consequences of high-fat diet feeding than male mice, for reasons that are incompletely understood. Here we identify sex-specific differences in hypothalamic microglial activation via the CX3CL1-CX3CR1 pathway that mediate the resistance of female mice to diet-induced obesity. Female mice fed a high-fat diet maintain CX3CL1-CX3CR1 levels while male mice show reductions in both ligand and receptor expression. FemaleCx3cr1knockout mice develop ‘male-like’ hypothalamic microglial accumulation and activation, accompanied by a marked increase in their susceptibility to diet-induced obesity. Conversely, increasing brain CX3CL1 levels in male mice through central pharmacological administration or virally mediated hypothalamic overexpression converts them to a ‘female-like’ metabolic phenotype with reduced microglial activation and body-weight gain. These data implicate sex differences in microglial activation in the modulation of energy homeostasis and identify CX3CR1 signalling as a potential therapeutic target for the treatment of obesity.

16 December 2016 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JDJohn D. Douglass
John D. Douglass
MDMauricio D. Dorfman
Mauricio D. Dorfman
JTJoshua P Thaler
Joshua P Thaler

11 August 2023 in Cell Metabolism
Verified
Journal Article
Closed access
JDJohn D. Douglass
John D. Douglass
KNKelly M. Ness
Kelly M. Ness
MVMartin Valdearcos
Martin Valdearcos
AWAlice Wyse-Jackson
Alice Wyse-Jackson
MDMauricio D. Dorfman
Mauricio D. Dorfman
JTJoshua P Thaler
Joshua P Thaler